The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.
Defined benefit plans guarantee a fixed payout, usually based on salary and years of service. Employers bear the investment risks and are responsible for funding these plans. Defined benefit plans ...